New Insight into the Impact of a Surveillance Strategy for Side-Branch Intraductal Pancreatic Mucinous Neoplasms
A recent analysis, led by Cleveland Clinic surgeon Matthew Walsh, MD, offers new insight into side-branch intraductal pancreatic mucinous neoplasms (SB-IPMNs) and the role of surveillance in clinical practice.